As of August 28, 2026, Liminatus Pharma, Inc. (LIMN) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. Liminatus Pharma, Inc. has a market capitalization of $7.36M, 67.16M shares outstanding, 15 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.19 below $1 exchange minimum
Market Data
Market Cap$7.36M
Shares Outstanding67.16M
Float29.07M
CashN/A
Debt$1.44M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 380.7% shares (2026Q1 vs prior)
15 institutional holders · 1.53M shares
#1
CITADEL ADVISORS LLC
677.5K shares
#2
Cygnus Capital Advisors, LLC
350.0K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
117.8K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest4.23M
Days to Cover1.0
% of Float14.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual LIMN Dilution Snapshot
Liminatus Pharma, Inc. (LIMN) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for LIMN: xbrl on 2026-06-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track LIMN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LIMN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for LIMN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.